Showing 601-610 of 1781 results for "".
MS Minute: Cognitive Dysfunction in People Living with Multiple Sclerosis
https://reachmd.com/diseases-diagnoses/ms-immune-disorders/ms-minute-cognitive-dysfunction-in-people-living-with-multiple-sclerosis/32170/Cognitive deficits are common in people with multiple sclerosis and affect multiple domains, including employment, activities of daily living, and relationships.Aesthetic Laser Innovators Discuss What Is Next
https://reachmd.com/programs/modern-aesthetics-focus-on-energy-based-devices/aesthetic-laser-innovators-discuss-what-is-next/56627/A roundtable discussion with Jill S. Waibel, MD, FACS, FAAD; R. Rox Anderson, MD, FAAD; Roy Geronemus, MD; and E. Victor Ross, MD, FAADThe New Heart of Medical Aesthetics Is Regenerative Medicine
https://reachmd.com/ma-issues-index/jan-feb-2026-issue/the-new-heart-of-medical-aesthetics-is-regenerative-medicine/54419/Exploring key mechanisms for future treatmentsUpdates to the McDonald Diagnostic Criteria for Multiple Sclerosis
https://reachmd.com/diseases-diagnoses/ms-immune-disorders/updates-to-the-mcdonald-diagnostic-criteria-for-multiple-sclerosis/54595/The 2024 revisions to the McDonald diagnostic criteria enable earlier identification and treatment of multiple sclerosis and potentially improve long-term prognosis.Once-Daily Oral Zasocitinib Demonstrates Rapid and Reproducible Skin Clearance with a Consistent Safety Profile in Moderate-to-Severe Plaque Psoriasis: Results from Two Randomized Phase 3 Trials (LATITUDE-PsO-3001 and 3002)
https://reachmd.com/clinical-practice/dermatology/once-daily-oral-zasocitinib-demonstrates-rapid-and-reproducible-skin-clearance-with-a-consistent-safety-profile-in-moderate-to-severe-plaque-psoriasis-results-from-two-randomized-phase-3-trials-latitude-pso-3001-and-3002/56617/Review Phase 3 trial data (LATITUDE-PsO-3001 and 3002) on once-daily oral zasocitinib in moderate-to-severe plaque psoriasis.Early Onset of Response to Zasocitinib (TAK-279), a Highly Selective and Potent TYK2 Inhibitor, Is Correlated With Modulation of TYK2 Signaling and Disease Pathway Biomarkers in Patients With Moderate-to-Severe Plaque Psoriasis
https://reachmd.com/clinical-practice/dermatology/early-onset-of-response-to-zasocitinib-tak-279-a-highly-selective-and-potent-tyk2-inhibitor-is-correlated-with-modulation-of-tyk2-signaling-and-disease-pathway-biomarkers-in-patients-with-moderate-to-severe-plaque-psoriasis/50977/Review phase 2b trial data on zasocitinib in patients with moderate-to-severe plaque psoriasis.Chloroquine as a Treatment Agent for COVID-19: Hype or Hope?
https://reachmd.com/programs/covid-19-frontlines/chloroquine-treatment-agent-covid-19-hype-or-hope/11323/Will the antimalarial drug chloroquine and its derivative, hydroxychloroquine, become effective COVID-19 treatment and prophylaxis agents?The History of Quarantine
https://reachmd.com/programs/covid-19-frontlines/the-history-of-quarantine/11419/Quarantines have been used all over the world amid our battle against COVID-19, but they’ve also been used in medicine for close to two centuries.Making Melanoma Diagnosis and Treatment More Predictable
https://reachmd.com/topics/skin-cancer-photoprotection/making-melanoma-diagnosis-and-treatment-more-predictable/37102/Melanoma can be a very humbling disease. Some of the most talented doctors have been challenged over the years when diagnosing and planning treatment for melanoma because of its variability.The Prognostic Utility of Neurofilament Light Chain in Multiple Sclerosis: A Narrative Review
https://reachmd.com/diseases-diagnoses/ms-immune-disorders/the-prognostic-utility-of-neurofilament-light-chain-in-multiple-sclerosis-a-narrative-review/32098/Neurofilament light chain has great promise as a prognostic biomarker in multiple sclerosis.